What is RVTY's health score?

REVVITY, INC. (RVTY) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RVTY's estimated fair value?

Based on our 5-year discounted cash flow model, REVVITY, INC.'s estimated fair value is $16.04 per share, representing a -84.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is RVTY undervalued or overvalued?

Our model currently rates RVTY as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RVTY... Refresh in a moment for the full analysis.

REVVITY, INC. (RVTY)

Healthcare Overvalued low weak

$102.4

Updated: 2026-06-05

TradeApes Score

Financial Strength

40 Weak

Operating Trend

30 Weak

Relative Value

25 Stressed

Capital Allocation

70 Healthy

Risk

50 Mixed

Est. Fair Value $16.04

DCF Upside -84.3%

Sector Rank #3930 of 6641

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.